DECAY-ACCELERATING FACTOR IS EXPRESSED IN THE HUMAN ENDOMETRIUM AND MAY SERVE AS THE ATTACHMENT LIGAND FOR DR PILI OF ESCHERICHIA-COLI

被引:16
作者
KAUL, A
NOWICKI, BJ
MARTENS, MG
GOLUSZKO, P
HART, A
NAGAMANI, R
KUMAR, D
PHAM, TQ
NOWICKI, S
机构
[1] UNIV TEXAS, MED BRANCH, SCH MED, DEPT OBSTET & GYNECOL, GALVESTON, TX 77555 USA
[2] UNIV TEXAS, MED BRANCH, DEPT MICROBIOL, GALVESTON, TX 77550 USA
[3] UNIV TEXAS, MED BRANCH, DEPT PATHOL, GALVESTON, TX 77550 USA
关键词
UROGENITAL TRACT; ESCHERICHIA-COLI; DR LIGANDS; COLONIZATION; DAF; DR FIMBRIAE;
D O I
10.1111/j.1600-0897.1994.tb01114.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
PROBLEM: We evaluated the hypothesis that different tissue substructures in uteri may express decay accelerating factor (DAF), a complement regulatory protein that also may serve as ligand for bacterial attachment. METHOD: Purified Dr pili, anti-Dr pili IgG, anti-DAF (SCR-3) IgG, and fluorescein-isothiocyanate-conjugated secondary IgG were used for binding and inhibition experiments. RESULT: We observed staining of endometrial glands, spiral arterioles, and myometrial arteries with Dr adhesin (pili) and anti-DAF (SCR-3) IgG, and found variation in distribution and amount of Dr ligands in different individuals. Anti-DAF (SCR-3) IgG blocked the binding of Dr pili to the endometrium. CONCLUSION: Presence of DAF in endometrium may protect tissues from complement-induced damage. Differences between individuals in DAF density in the endometrium may affect sensitivity to attachment of Dr-bearing E. coli and/or complement activation.
引用
收藏
页码:194 / 199
页数:6
相关论文
共 18 条
[1]  
CUNNINGHAM FG, 1978, OBSTET GYNECOL, V52, P161
[2]  
DUGUID JP, 1980, BACTERIAL ADHERENC B, V6, P185
[3]  
FRANKLIN WA, 1987, ANAL QUANT CYTOL, V9, P279
[4]  
HASTY LA, 1994, AM J OBSTET GYNECOL, V170, P168
[5]   THE REGULATORS OF COMPLEMENT ACTIVATION (RCA) GENE-CLUSTER [J].
HOURCADE, D ;
HOLERS, VM ;
ATKINSON, JP .
ADVANCES IN IMMUNOLOGY, 1989, 45 :381-416
[6]   NEW METHOD FOR ISOLATION OF IMMUNOLOGICALLY PURE PILI FROM ESCHERICHIA-COLI [J].
KORHONEN, TK ;
NURMIAHO, EL ;
RANTA, H ;
SVANBORGEDEN, C .
INFECTION AND IMMUNITY, 1980, 27 (02) :569-575
[7]  
KORHONEN TK, 1986, PROTEIN CARBOHYDRATE, P245
[8]  
LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.iy.07.040189.000343
[9]   MOLECULAR ANALYSIS AND EPIDEMIOLOGY OF THE DR HEMAGGLUTININ OF UROPATHOGENIC ESCHERICHIA-COLI [J].
NOWICKI, B ;
SVANBORGEDEN, C ;
HULL, R ;
HULL, S .
INFECTION AND IMMUNITY, 1989, 57 (02) :446-451
[10]   IMMUNOFLUORESCENCE STUDY OF FIMBRIAL PHASE VARIATION IN ESCHERICHIA-COLI KS71 [J].
NOWICKI, B ;
RHEN, M ;
VAISANENRHEN, V ;
PERE, A ;
KORHONEN, TK .
JOURNAL OF BACTERIOLOGY, 1984, 160 (02) :691-695